Literature DB >> 675836

A transepidermal chemotherapy of onchocerciasis.

M E Langham, Z D Traub, R Richardson.   

Abstract

Counts of microfilariae in the skin, and histological and electronmicroscopic procedures have been used to analyze the response of onchocerciasis patients to diethylcarbamazine citrate (DEC) given either orally or topically. Oral administration of DRC failed to eliminate all microfilariae. Transepidermal DEC resulted in rapid degeneration of microfilariae, and daily single applications of the drug greatly reduced or apparently eliminated microfilariae from the skin. Following weekly topical applications of a DEC emulsion, effective suppression of O. volvulus microfilariae in patients living in a hyperendemic area was maintained for many months; and the dermal pathology resolved.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 675836

Source DB:  PubMed          Journal:  Tropenmed Parasitol        ISSN: 0303-4208


  5 in total

Review 1.  Diethylcarbamazine in the treatment of patients with onchocerciasis.

Authors:  K Awadzi; H M Gilles
Journal:  Br J Clin Pharmacol       Date:  1992-10       Impact factor: 4.335

Review 2.  Clinical pharmacokinetics of anthelmintic drugs.

Authors:  G Edwards; A M Breckenridge
Journal:  Clin Pharmacokinet       Date:  1988-08       Impact factor: 6.447

3.  The effect of moderate urine alkalinisation on low dose diethylcarbamazine therapy in patients with onchocerciasis.

Authors:  K Awadzi; K K Adjepon-Yamoah; G Edwards; M L Orme; A M Breckenridge; H M Gilles
Journal:  Br J Clin Pharmacol       Date:  1986-06       Impact factor: 4.335

4.  Ocular changes with oral and transepidermal diethylcarbamazine therapy of onchocerciasis.

Authors:  H R Taylor; B M Greene
Journal:  Br J Ophthalmol       Date:  1981-07       Impact factor: 4.638

5.  Treatment of filariasis-diethylcarbamazine and its congeners.

Authors:  S Sharma
Journal:  Pharm Res       Date:  1986-04       Impact factor: 4.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.